Ivermectin and piperazine toxicoses in dogs and cats.
Review of all reports involving anthelmintics in dogs and cats to the IAPIC between January 1, 1986 and August 10, 1988, revealed that ivermectin (extra-label use) and piperazine accounted for over 50% of the calls assessed as toxicoses and suspected toxicoses. Both ivermectin and piperazine are gamma-aminobutyric acid (GABA) agonists and their major effects appear to be on the central nervous system. Ivermectin toxicoses at estimated doses of greater than or equal to 100-less than 500 micrograms/kg were reported more than once only in the collies (n = 25) and Australian shepherds (n = 10); these two breeds accounted for 46% (69 of 150) of the toxicoses and suspected toxicoses calls in dogs. Ataxia, behavioral disturbances, tremors, mydriasis, weakness/recumbency, apparent blindness, hypersalivation/drooling (dogs only), and coma were the most commonly reported clinical signs in dogs and cats with suspected ivermectin toxicoses. Shock, dyspnea, vomiting, and ataxia were the most common clinical signs attributed to the microfilaricidal activity of ivermectin. Piperazine was the anthelmintic with the greatest number of reports of toxicoses and suspected toxicoses in cats. Piperazine neurotoxicity in cats and dogs usually was manifested by muscle tremors, ataxia, and/or behavioral disturbances within 24 hours after estimated daily dose(s) between 20 and 110 mg/kg.
Lovell
R A
RA
Ricerca, Inc., Toxicology and Animal Metabolism, Painesville, Ohio.
D000818:Animals; D002371:Cat Diseases / Q000139:chemically induced*; D002415:Cats; D004283:Dog Diseases / Q000139:chemically induced*; D004285:Dogs; D007559:Ivermectin / Q000506:poisoning*; D000077489:Piperazine; D010879:Piperazines / Q000506:poisoning*
D010879:Piperazines; D000077489:Piperazine; D007559:Ivermectin